Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness.
A novel arabinogalactan-, hyaluronic acid-, and trehalose-containing artificial tear improves dry eye disease symptoms.
An FDA optometry roundup discusses changes in drug approvals and devices used by optometric eye care professionals.
FDA alerts and updates on the latest drug and device approvals, recalls, and other regulatory developments in ophthalmology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback